BSE filing, NSE: ANG. Summary written from the filing by ALFA Finder's alert engine.
ANG Lifesciences India Ltd: key numbers
- Share price
- ₹33.50
- Market cap
- ₹43.75 Cr
- Revenue (annual)
- ₹92.89 Cr
- Net profit (annual)
- ₹-11.08 Cr
- P/E (TTM)
- -3.3×Sector 46.1×
- Promoter holding
- 70.60%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ANG Lifesciences India Ltd
All →ANG Lifesciences India Other Announcement
The company filed its quarterly shareholding pattern for the period ending September 30, 2026, as per SEBI regulations.
ANG Lifesciences India Management Change
ANG Lifesciences India Ltd announced the re-appointment of Mrs. Chetna as an Independent Director for a second five-year term, effective October 12, 2026.
ANG Lifesciences India Annual General Meeting
ANG Lifesciences India Limited held its 20th Annual General Meeting on September 30, 2026. The meeting successfully transacted routine business items.
ANG Lifesciences India Other Announcement
ANG Lifesciences India Ltd has filed its quarterly shareholding pattern as required under SEBI Regulation 31(1)(b).
ANG Lifesciences India Annual Report
ANG Lifesciences India Limited has submitted its Annual Report for the financial year 2025-26, including the notice convening its 20th Annual General Meeting.
ANG Lifesciences India Annual General Meeting
ANG Lifesciences India Limited has scheduled its 20th Annual General Meeting for September 30, 2026, to be conducted via Video Conference.
Other board meeting date announcements
All →Tatia Global Vennture Board Meeting Date
Tatia Global Vennture will hold a board meeting on 05 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes 01 Oct to 07 Nov 2026.
Landmarc Leisure Corporation Board Meeting Date
Landmarc Leisure scheduled a board meeting for 06 Nov 2026 to approve Q2 FY27 results. Trading window closes from 01 Oct to 08 Nov 2026.
Augmont Enterprises Board Meeting Date
Augmont Enterprises scheduled a Board meeting for November 4, 2026, to approve unaudited Q1 and H1 financial results. Trading window remains closed until 48 hours post-declaration.
Linc Board Meeting Date
Linc Ltd announced that its Board of Directors meeting is scheduled for 5 November 2026. The agenda includes approval of unaudited financial results for Q1 and H1 FY27.
NDR Auto Components Board Meeting Date
NDR Auto Components intimated its board meeting for November 4, 2026, to approve Q1 and H1 FY27 results. No financial figures are reported.
Reliance Chemotex Industries Board Meeting Date
Reliance Chemotex notified a Board Meeting on 05 Nov 2026 to approve unaudited results for Q1 FY27. No financial figures or decisions are yet reported.